@article{f4019b740d194eacb964f338bfeef19e,
title = "Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY",
abstract = "N/A",
keywords = "Bevacizumab, Fluoresceins, Follow-Up Studies, Humans, Infant, Intravitreal Injections, Newborn, Retinopathy of Prematurity, Bevacizumab, Fluoresceins, Follow-Up Studies, Humans, Infant, Intravitreal Injections, Newborn, Retinopathy of Prematurity",
author = "Domenico Lepore and Ji, \{M. H.\} and G. Quinn",
year = "2018",
doi = "10.1016/j.ophtha.2018.04.012",
language = "English",
volume = "125",
pages = "e71--e72",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "10",
}